Copper

Evidence status

Limited evidence to recommend for any consumer outcome yet.

6 papers · 1 claim · 11 outcomes scored

Outcomes

What copper actually does, by outcome

Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.

Outcome Effect size Evidence Dose Weeks Rank

Build key mineral stores Not enough research

Essential mineral blood levels rise into optimal range, confirming absorption.

1 study n=— 10 mg 8 wk

15579408

—

1 study n=—

10 mg

8 wk

—

Outcome	Effect	Evidence	Dose	Weeks	Rank
Build key mineral stores Not enough research		1 study n=—	10 mg	8 wk	—

Risk profile

Adverse events and known drug interactions

Safety events

intracranial hemorrhage (hospitalization) severe

suspected cerebral infarction (hospitalization) severe

diagnosis of non-Hodgkin lymphoma (hospitalization) severe

skin irritation mild

headache mild

metallic taste mild

nausea mild

hearing_impairment mild

Drug interactions

Lovastatin major decreases effect

Roxadustat major increases concentration

Metformin major decreases concentration

Carbamazepine moderate increases concentration

Sodium Valproate moderate increases concentration

Phenytoin moderate increases concentration

Clonazepam moderate increases concentration

Levetiracetam moderate increases concentration

other moderate additive

Sources

Generated August 14, 2026